Illuminating Phenylketonuria

lab_biotech_test_big-1

Phenylketonuria (PKU) is a rare autosomal recessive condition caused by mutations in the phenylalanine-4-hydroxylase (PAH) gene. This gene is involved in the production of the PAH enzyme. Since this enzyme is necessary for the breakdown of the amino acid phenylalanine, its deficiency leads to an accumulation of phenylalanine in the blood. If untreated, the toxic effects of phenylalanine can lead to severe and permanent intellectual impairment. Other symptoms of untreated PKU include neurological issues, eczematous rash, motor deficits, delayed development, and behavioral and psychiatric problems.

PKU Awareness Day, which was on December 3, reminds us of the importance of promoting patient care and support, driving research, and accelerating the timeline for a cure.

Universal newborn screening

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical